Position
Independent Director
Company
InMed Pharmaceuticals
VancouverHealthcareDescription
InMed Pharmaceuticals has appointed several new independent members to its Board of Directors. The newly appointed directors include Julianne Bruno, Michelle Pernice, Laura Sandler, and Todd Shegog, who all meet the independence criteria as defined by Nasdaq listing rules. This strategic move is aimed at enhancing governance and oversight within the company.
Quick answer
InMed Pharmaceuticals Appoints New Independent Directors (November 10, 2026). InMed Pharmaceuticals is based in Vancouver, British Columbia, Canada.
- What did InMed Pharmaceuticals announce on November 10, 2026?
- InMed Pharmaceuticals has appointed several new independent members to its Board of Directors. The newly appointed directors include Julianne Bruno, Michelle Pernice, Laura Sandler, and Todd Shegog, who all meet the independence criteria as defined by Nasdaq listing rules.
- What does InMed Pharmaceuticals do?
- InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids.
- Where is InMed Pharmaceuticals based?
- InMed Pharmaceuticals is based in Vancouver, British Columbia, Canada.
- Which similar companies made leadership changes around the same time?
- Immuneering (November 9, 2026), Fractyl Health (November 6, 2026), Element Science, Inc. (November 6, 2026) and Change Agents Corporation. (November 5, 2026) also announced leadership changes within 45 days of InMed Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Grant C. Bogle Appointed as Class III Director at Immuneering Corporation (November 9, 2026)
- Fractyl Health Appoints Michael Wartell as Independent Director (November 6, 2026)
- Element Science Appoints Paul Mandina as Chief Revenue Officer and Mark Hughes as Chief Operating Officer (November 6, 2026)
- Change Agents Corporation Appoints Luisa Ingargiola as Principal Executive Officer (November 5, 2026)
- Leadership Transition at Ensysce Biosciences (November 4, 2026)
- RevMedica Appoints Mike Jones as Chief Executive Officer (November 4, 2026)
Who to call at InMed Pharmaceuticals, and when
A new leader at InMed Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day InMed Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at InMed Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at InMed Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment InMed Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
InMed Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.